Anti-TRIM55 monoclonal antibody

Pre-made anti-TRIM55 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRIM55/TRIM55 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2177-Ab-1/ GM-Tg-hg-IP2177-Ab-2Anti-Human TRIM55 monoclonal antibodyHuman
GM-Tg-rg-IP2177-Ab-1/ GM-Tg-rg-IP2177-Ab-2Anti-Rat TRIM55 monoclonal antibodyRat
GM-Tg-mg-IP2177-Ab-1/ GM-Tg-mg-IP2177-Ab-2Anti-Mouse TRIM55 monoclonal antibodyMouse
GM-Tg-cynog-IP2177-Ab-1/ GM-Tg-cynog-IP2177-Ab-2Anti-Cynomolgus/ Rhesus macaque TRIM55 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2177-Ab-1/ GM-Tg-felg-IP2177-Ab-2Anti-Feline TRIM55 monoclonal antibodyFeline
GM-Tg-cang-IP2177-Ab-1/ GM-Tg-cang-IP2177-Ab-2Anti-Canine TRIM55 monoclonal antibodyCanine
GM-Tg-bovg-IP2177-Ab-1/ GM-Tg-bovg-IP2177-Ab-2Anti-Bovine TRIM55 monoclonal antibodyBovine
GM-Tg-equg-IP2177-Ab-1/ GM-Tg-equg-IP2177-Ab-2Anti-Equine TRIM55 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2177-Ab-1/ GM-Tg-hg-IP2177-Ab-2; GM-Tg-rg-IP2177-Ab-1/ GM-Tg-rg-IP2177-Ab-2;
GM-Tg-mg-IP2177-Ab-1/ GM-Tg-mg-IP2177-Ab-2; GM-Tg-cynog-IP2177-Ab-1/ GM-Tg-cynog-IP2177-Ab-2;
GM-Tg-felg-IP2177-Ab-1/ GM-Tg-felg-IP2177-Ab-2; GM-Tg-cang-IP2177-Ab-1/ GM-Tg-cang-IP2177-Ab-2;
GM-Tg-bovg-IP2177-Ab-1/ GM-Tg-bovg-IP2177-Ab-2; GM-Tg-equg-IP2177-Ab-1/ GM-Tg-equg-IP2177-Ab-2
Products NameAnti-TRIM55 monoclonal antibody
Formatmab
Target NameTRIM55
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRIM55 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2177-Ag-1Recombinant multi-species TRI55/ TRIM55/ MURF-2 protein


    Target information

    Target IDGM-IP2177
    Target NameTRIM55
    Gene ID84675,381485,365751,711707,486976,101088139,616362,100052338
    Gene Symbol and SynonymsD830041C10Rik,MURF-2,muRF2,RNF29,TRIM55
    Uniprot AccessionQ9BYV6,Q5PQN5
    Uniprot Entry NameTRI55_HUMAN,TRI55_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000147573
    Target ClassificationN/A

    The target: TRIM55, gene name: TRIM55, also named as MURF-2, RNF29, muRF2. The protein encoded by this gene contains a RING zinc finger, a motif known to be involved in protein-protein interactions. This protein associates transiently with microtubules, myosin, and titin during muscle sarcomere assembly. It may act as a transient adaptor and plays a regulatory role in the assembly of sarcomeres. Four alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.